Perioperative prostaglandin E1 treatment for the prevention of postoperative complications after esophagectomy: A randomized clinical trial

Surgery Today

Volumn 34, Issue 8, 2004, Pages 662-667

  Oda, Kazushige ^a   Akiyama, Seiji ^a   Ito, Katsuki ^a   Kasai, Yasusi ^a   Fujiwara, Michitaka ^a   Sekiguchi, Hiroyuki ^a   Nakao, Akimasa ^a   Sakamoto, Junichi ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Esophagectomy; Postoperative complications; Prostaglandin E1; Systemic inflammatory response syndrome

Indexed keywords

BILIRUBIN; PROSTAGLANDIN E1;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; INTENSIVE CARE UNIT; LYMPHADENECTOMY; MALE; PERIOPERATIVE PERIOD; PLEURA EFFUSION; PORTAL VEIN BLOOD FLOW; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURGICAL MORTALITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 4043059352     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-004-2791-8     Document Type: Article

References (26)

1. Rakic S, Pesko P, Milicevic M, Gerzic Z. Atrophic chronic gastritis and esophagogastric anastomotic leak after resection and reconstruction for esophageal carcinoma. J Surg Oncol 1992;51: 19-21.
2. Patil PK, Patel SG, Mistry RC, Deshpande RK, Desai PB. Cancer of the esophagus: esophagogastric anastomotic leak - a retrospective study of predisposing factors. J Surg Oncol 1992;49:163-7.
3. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-73.
4. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, Le Saffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216:583-90.
5. Akiyama S, Ito S, Sekiguchi H, Fujiwara M, Sakamoto J, Kondo K, et al. Preoperative embolization of gastric arteries for esophageal cancer. Surgery 1996;120:542-6.
6. Imamura M, Yanagibashi K, Tobe T, Shimada Y, Naito M, Arai T, et al. Transthoracic resection of esophageal cancer in patients with pulmonary dysfunction. Ann Surg 1988;268:601-5.
7. Hanazaki K, Kuroda T, Kajikawa S, Shiohara E, Haba Y, Iida F. Prostaglandin E1 protects liver from ischemic damage. J Surg Res 1994;57:380-4.
8. Beck PL, McKnight GW, Kelly JK, Wallace JL, Lee SS. Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats. Gastroenterology 1993;105:1483-9.
9. Haynes DR, Whitehouse NW, Vernon-Roberts B. The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vivo like the natural prostaglandin E1, E2 and E3. Immunology 1992;76:251-7.
10. Laitinen LA, Robinson NP, Laitinen A, Widdicombe JG. Relationship between tracheal mucosal thickness and vascular resistance in dogs. J Appl Physiol 1986;61:2186-93.
11. Carlson LA, Olsson AG. Intravenous prostaglandin E1 in severe peripheral vascular disease. Lancet 1976;2:810.
12. Mansour KA, Downey RS. Esophageal carcinoma: surgery without preoperative adjuvant chemotherapy. Ann Thorac Surg 1989; 48:201-5.
13. Members of the American College of Chest Physicians / Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians / Society of Critical Care Medicine Conference; definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864.
14. Sinclair S, Levy G. Eicosanoids and the liver. Ital J Gastroenterol 1990;22:205-13.
15. Nakano J, Cole B, Effects of prostaglandin E1, E2, A1 and F1 α on systemic, pulmonary, and splanchnic circulations in dogs. Am J Physiol 1969;217:222-7.
16. Davies MG, Hagen PO. The vascular endotherlium. Ann Surg 1993;218:593-609.
17. Himmelreich G, Hundt K, Neuhaus P, Bechstein O, Roissant R, Riess H. Evidence that intraoperative prostaglandin E1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation. Transplantation 1993;55:819-926.
18. Hooper TL, Thomson DS, Jones MT, Cook L, Owen S, Wilkes S, et al. Amelioration of lung ischemic injury with prostacyclin. Transplantation 1990;49:1031-5.
19. Beak Y, Nakano H, Kumada K, Nagasaki H, Kigawa G, Sasaki J, et al. Administration of prostaglandin E1 reduces postoperative hepatocellular damage and restores hepatic integrity in patients undergoing hepatectomy. Hepatogastroenterology 1999;46:1836-41.
20. Une Y, Shimamura T, Uchino J. Effect of prostaglandin E1 on hepatic function after hepatectomy in patients chronic liver disease. Clin Ther 1995;6:1118-25.
21. Sugawara Y, Kubota K, Ogura T, Esumi H, Inoue K, Takayama T, et al. Protective effect of prostaglandin E1 against ischemia/ reperfusion-induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. J Hepatol 1998;29:969-76.
22. Henley KS, Lucey MR, Normolle DP, Merion RM, McLaren ID, Crider BA, et al. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology 1995;21:366-72.
23. Klein AS, Cofer JB, Pruett TL, Thuluvath PJ, McGory R, Uber L, et al. Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology 1996;111:710-5.
24. Matsuzaki Y, Edagawa M, Maeda M, Shimizu T, Sekiya R, Nakamura K, et al. Beneficial effect of prostaglandin E1 on blood flow to the gastric tube after esophagectomy. Ann Thorac Surg 1999;67:908-10.
25. Hasegawa S, Imamura M, Shimada Y, Kanda Y, Wada H, Hitomo S, et al. Prostaglandin E1 ameliorates decreased tracheal blood flow after esophagectomy and aggressive upper mediastinal lymphadenectomy for esophageal carcinoma. J Am Coll Surg 1996;183:371-6.
26. Tsujikawa T, Kido Y, Ogawa M, Shiozaki H, Murata A, Kobayashi K, et al. Postoperative hyperbilirubinemia after resection of thoracic esophageal cancer. Am J Gastroenterol 1990; 85:1473-9.